Enlightenment Research, LLC Baxter International Inc Transaction History

Enlightenment Research, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	SELL	$63.83 - $80.0 $280,341 - $351,360	-4,392 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$76.85 - $89.45 $337,525 - $392,864	4,392 New	4,392 $341,000
Q2 2021 Aug 16, 2021	SELL	$80.5 - $88.01 $225,400 - $246,428	-2,800 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$76.38 - $86.03 $213,864 - $240,884	2,800 New	2,800 $236,000
Q3 2019 Oct 16, 2019	SELL	$81.4 - $89.78 $504,680 - $556,636	-6,200 Closed	0 $0
Q2 2019 Aug 05, 2019	BUY	$73.44 - $82.41 $455,328 - $510,942	6,200 New	6,200 $473,000
Q1 2019 May 03, 2019	SELL	$64.48 - $81.31 $109,616 - $138,227	-1,700 Closed	0 $0
Q4 2018 Feb 06, 2019	BUY	$61.45 - $77.8 $104,465 - $132,260	1,700 New	1,700 $112,000

1,006

451M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $16.6B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Enlightenment Research, LLC, based on Form 13F filings with the SEC.

Stay updated on Enlightenment Research, LLC with notifications on news.